Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Amgen Inc. (AMGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 127,784,048
  • Shares Outstanding, K 647,270
  • Annual Sales, $ 22,849 M
  • Annual Income, $ 1,979 M
  • 36-Month Beta 1.36
  • Price/Sales 5.56
  • Price/Cash Flow 12.73
  • Price/Book 8.53

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 3.38
  • Number of Estimates 10
  • High Estimate 3.71
  • Low Estimate 3.12
  • Prior Year 3.27
  • Growth Rate Est. (year over year) +3.36%

Price Performance

See More
Period Period Low Period High Performance
1-Month
189.16 +4.44%
on 07/23/18
200.90 -1.66%
on 08/07/18
+7.07 (+3.71%)
since 07/20/18
3-Month
175.77 +12.40%
on 05/29/18
200.90 -1.66%
on 08/07/18
+21.26 (+12.06%)
since 05/18/18
52-Week
163.31 +20.97%
on 04/02/18
201.23 -1.82%
on 01/29/18
+30.27 (+18.09%)
since 08/18/17

Most Recent Stories

More News
Amgen Stock Up This Year So Far: Will the Rally Continue?

After a relatively strong performance so far this year, let's see how things are poised for Amgen (AMGN) in the second half of the year.

AGN : 190.75 (+2.77%)
NVS : 83.56 (+0.63%)
RHHBY : 30.5350 (+1.38%)
AMGN : 197.56 (+0.07%)
Allergan's (AGN) Stock Up 4.2% Since Q2 Earnings: Here's Why

Allergan (AGN) is having a relatively better 2018 with the stock on an upward trajectory since announcement of earnings in July. Let us have a look at the reasons for the same.

AGN : 190.75 (+2.77%)
EDIT : 30.41 (+1.84%)
RHHBY : 30.5350 (+1.38%)
AMGN : 197.56 (+0.07%)
Top Research Reports: UnitedHealth, PepsiCo, Amgen & More

Top Research Reports: UnitedHealth, PepsiCo, Amgen & More

TXT : 67.65 (+1.50%)
MYL : 38.41 (+0.68%)
ABB : 22.74 (+0.89%)
PEP : 114.84 (-0.10%)
AMGN : 197.56 (+0.07%)
UNH : 262.40 (+0.03%)
Here's Why Merck (MRK) Stock is Up Since Q2 Earnings Release

Merck's (MRK) stock is up 4.2% since announcement of earnings in July. Let us have a look at the reasons for the same.

AZN : 38.85 (+1.92%)
MRK : 70.17 (+1.61%)
INCY : 69.05 (+0.36%)
AMGN : 197.56 (+0.07%)
Here's Why Lilly (LLY) Stock is Up 15% Since Q2 Earnings

Eli Lilly's (LLY) stock is up 15% since announcement of earnings in July. Let us have a look at the reasons for the same.

LLY : 105.82 (+0.26%)
NVS : 83.56 (+0.63%)
TEVA : 25.65 (+5.90%)
AMGN : 197.56 (+0.07%)
Biotech ETFs in Focus on String of Q2 Earnings Beat

Biotech ETFs draw attention post impressive Q2 results.

IBB : 116.09 (-0.17%)
FBT : 149.52 (-0.16%)
BBH : 129.46 (+0.05%)
IEIH : 26.23 (unch)
GILD : 72.36 (-0.77%)
AMGN : 197.56 (+0.07%)
ALXN : 116.17 (+0.15%)
BIIB : 344.11 (-0.32%)
Spectrum (SPPI) Earnings and Sales Miss Estimates in Q2

Spectrum (SPPI) reports wider-than-expected loss in the second quarter and misses on revenues. Rolontis successful in second phase III study.

SPPI : 23.14 (+1.58%)
VRTX : 175.71 (-0.21%)
SGEN : 74.45 (-0.25%)
AMGN : 197.56 (+0.07%)
Biotech ETFs in Focus on String of Q2 Earnings Beat

Biotech ETFs draw attention post impressive Q2 results.

IBB : 116.09 (-0.17%)
FBT : 149.52 (-0.16%)
BBH : 129.46 (+0.05%)
IEIH : 26.23 (unch)
GILD : 72.36 (-0.77%)
AMGN : 197.56 (+0.07%)
ALXN : 116.17 (+0.15%)
BIIB : 344.11 (-0.32%)
Recommended Cash Offer for Vernalis plc

LNSTY : 14.2900 (-0.56%)
MRK : 70.17 (+1.61%)
BK : 51.94 (+0.48%)
BAX : 72.20 (+0.22%)
NVS : 83.56 (+0.63%)
VNLPF : 0.2190 (unch)
AMGN : 197.56 (+0.07%)
BIIB : 344.11 (-0.32%)
Frazier Healthcare Partners Adds Two Experienced Professionals to Life Sciences Team

Frazier Healthcare Partners announced the addition of two new members to its Life Sciences team: Tracy Saxton, Ph.D. as an Entrepreneur-in-Residence (EIR), and Vanessa Bhark as a Senior Associate....

AMGN : 197.56 (+0.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade AMGN with:

Business Summary

Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice...

See More

Key Turning Points

2nd Resistance Point 199.27
1st Resistance Point 198.42
Last Price 197.56
1st Support Level 196.79
2nd Support Level 196.01

See More

52-Week High 201.23
Last Price 197.56
Fibonacci 61.8% 186.74
Fibonacci 50% 182.27
Fibonacci 38.2% 177.80
52-Week Low 163.31

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar